NCT03519243View on ClinicalTrials.gov

Comparative Study of the Efficacy and Safety of BCD-131 and Mircera in Treatment of Anemia in CKD Patients on Dialysis

PHASE2CompletedINTERVENTIONAL
Enrollment

75

Participants

Timeline

Start Date

October 24, 2017

Primary Completion Date

December 1, 2018

Study Completion Date

December 10, 2018

Conditions
Anemia
Interventions
BIOLOGICAL

BCD-131

subcutaneously monthly

BIOLOGICAL

Mircera

subcutaneously monthly

Trial Locations (3)

194104

City Mariin Hospital, Saint Petersburg

Unknown

City Clinical Hospital №9, Minsk

B.Braun Avitum Russland Clinics Ltd., Saint Petersburg

Sponsors

Lead Sponsor

Biocad
All Listed Sponsors
lead

Biocad

INDUSTRY

NCT03519243 - Comparative Study of the Efficacy and Safety of BCD-131 and Mircera in Treatment of Anemia in CKD Patients on Dialysis | Biotech Hunter | Biotech Hunter